Analyst Expectations for Cogent Biosciences's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for Cogent Biosciences (NASDAQ:COGT) with an average price target of $17.0, which is significantly higher than its current price of $4.96. The current average price target has decreased by 27.66% from the previous target of $23.50. Over the past three months, Cogent Biosciences has received 4 bullish, 1 somewhat bullish, and 1 indifferent rating from analysts.
December 15, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a positive outlook on Cogent Biosciences with a high average price target of $17 compared to its current price of $4.96, indicating a significant potential upside.
The average price target provided by analysts is substantially higher than the current stock price, which typically suggests a bullish sentiment and potential for short-term price increase. However, the decrease in the average price target may indicate some caution, hence the confidence is not at the maximum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100